Skip to main content
Caplight Logo









Pabel B.V.

Pabel B.V.

Private
AmsterdamHealthcare & Life Scienceshttps://www.pabel.ai/

Last Round

Accelerator

Oct 21, 2025

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Pabel B.V. is a biotechnology and artificial intelligence company that develops an AI-native platform for analyzing and processing neurophysiological data to accelerate CNS drug development.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Drug Discovery, Healthcare Analytics, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Foundation

Keywords

EEG analysisneurophysiological databiomarker discoveryCNS drug developmentelectroencephalogramEEGfoundation modelmedical AIclinical trial softwarepreclinical researchdigital biomarkersAI drug discoverytranslational researchfrontier AI labhealthtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pabel B.V. Comparables

Compare Pabel B.V. with similar companies based on industry and business-model similarity.

Pabel B.V. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Beacon Biosignals
77%
Cumulus Neuroscience
75%
NeuraLight
66%

Pabel B.V. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorOct 21, 2025

Pabel B.V. Investors

Notable investors and investment history

Pabel B.V. investors
InvestorRounds
Nvidia InceptionAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 21, 2025

    Received funding from Google for Startups and Nvidia Inception.

Pabel B.V. Filings

Explore SEC and related filing metadata, where available.

Pabel B.V. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Pabel B.V.'s valuation, stock price, and market status.

Is Pabel B.V. a public or private company?

Pabel B.V. is a private company.

What is the current stock price of Pabel B.V.?

Pabel B.V. is a private company with no public stock price. No recent secondary market data is available.

How much is Pabel B.V. worth (valuation)?

Valuation information for Pabel B.V. is not publicly available.

Can I buy Pabel B.V. stock?

Pabel B.V. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Pabel B.V.'s last funding round?

Pabel B.V.'s most recent funding round was Accelerator on October 21, 2025.

Who are the main investors in Pabel B.V.?

Key investors in Pabel B.V. include Nvidia Inception.

Will Pabel B.V. IPO soon?

No public IPO plans have been announced for Pabel B.V..

How can I track Pabel B.V. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pabel B.V.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAmsterdam
Employee Range2
Year Founded2025
Last FundingOct 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?